Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy
Bayan Al-Share et al.
CANCER AND METASTASIS REVIEWS (2021)
Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer
Mingyang Liu et al.
GASTROENTEROLOGY (2021)
WWC Proteins: Important Regulators of Hippo Signaling in Cancer
Verena Hoffken et al.
CANCERS (2021)
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
David J. Birnbaum et al.
CLINICAL CANCER RESEARCH (2021)
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation
Timothy H. Tran et al.
NATURE COMMUNICATIONS (2021)
Cell of Origin Influences Pancreatic Cancer Subtype
Brittany M. Flowers et al.
CANCER DISCOVERY (2021)
The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
Andres Garcia-Sampedro et al.
JOURNAL OF CLINICAL MEDICINE (2021)
RAS Nanoclusters: Dynamic Signaling Platforms Amenable to Therapeutic Intervention
Que N. Van et al.
BIOMOLECULES (2021)
Tumor cell heterogeneity and its transcriptional bases in pancreatic cancer: a tale of two cell types and their many variants
Marta Milan et al.
EMBO JOURNAL (2021)
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes
Michael Eyres et al.
GASTROENTEROLOGY (2021)
Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis
Michael P. Kim et al.
CANCER DISCOVERY (2021)
The Role of Wild-Type RAS in Oncogenic RAS Transformation
Erin Sheffels et al.
GENES (2021)
Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
Yong Suk Cho et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Kazuhiro Koikawa et al.
CELL (2021)
Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition
Maria A. Ortiz et al.
CELL COMMUNICATION AND SIGNALING (2021)
Emerging strategies to target RAS signaling in human cancer therapy
Kun Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The pancreatic cancer genome revisited
Akimasa Hayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma
Thomas J. George et al.
ONCOLOGIST (2021)
The value of GATA6 immunohistochemistry and computer-assisted diagnosis to predict clinical outcome in advanced pancreatic cancer
Kai Duan et al.
SCIENTIFIC REPORTS (2021)
Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation
Takeshi Tamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk et al.
NATURE REVIEWS CANCER (2021)
The Ras dimer structure
Till Rudack et al.
CHEMICAL SCIENCE (2021)
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BIOESSAYS (2020)
y The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma
Ho-June Lee et al.
CANCER RESEARCH (2020)
CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
Yong Suk Cho et al.
GENES & DEVELOPMENT (2020)
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
Michelle Chan-Seng-Yue et al.
NATURE GENETICS (2020)
Targeting the MAPK Pathway in KRAS-Driven Tumors
Matthias Drosten et al.
CANCER CELL (2020)
GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Grainne M. O'Kane et al.
CLINICAL CANCER RESEARCH (2020)
MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway
Liwei An et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
RAF kinase dimerization: implications for drug discovery and clinical outcomes
Tilman Brummer et al.
ONCOGENE (2020)
Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype
Natalia Juiz et al.
FASEB JOURNAL (2020)
Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned So Far
Stefano Martellucci et al.
CANCERS (2020)
Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1
Chi Ben et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma
EeeLN H. Buckarma et al.
MOLECULAR CANCER RESEARCH (2020)
Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation
Laszlo Buday et al.
CANCER AND METASTASIS REVIEWS (2020)
YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice
Jaeoh Park et al.
CANCER RESEARCH (2020)
Yap/Taz promote the scavenging of extracellular nutrients through macropinocytosis
Bryan King et al.
GENES & DEVELOPMENT (2020)
Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes
Koji Miyabayashi et al.
CANCER DISCOVERY (2020)
Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis
Loredana Moro et al.
NATURE CELL BIOLOGY (2020)
RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway
Thillaivillalan Dhanaraman et al.
SCIENCE SIGNALING (2020)
PTPN2 regulates the activation of KRAS and plays a critical role in proliferation and survival of KRAS-driven cancer cells
Zhangsen Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Akimasa Hayashi et al.
NATURE CANCER (2020)
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Guido Eibl et al.
SEMINARS IN CANCER BIOLOGY (2019)
Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma
Alex Y. L. Lee et al.
GUT (2019)
Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
Ruth Nussinov et al.
SEMINARS IN CANCER BIOLOGY (2019)
Ras-Mediated Activation of the Raf Family K nases
Elizabeth M. Terrell et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
A phase I study of gemcitabine plus dasatinib (gd) or gemcitabine plus dasatinib plus cetuximab (GDC) in refractory solid tumors
Niharika B. Mettu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
Austin R. Dosch et al.
Oncotarget (2019)
SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors
Hengyu Lu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
Enrique Rozengurt et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications
S. Martens et al.
ANNALS OF ONCOLOGY (2019)
Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice
Fang Hao et al.
PLOS ONE (2019)
Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases
JinSeok Park et al.
NATURE COMMUNICATIONS (2019)
MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer
Ramazan Gundogdu et al.
CELLS (2019)
Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy
Ashleigh Parkin et al.
FEBS JOURNAL (2019)
Activation of the intrinsic fibroinflammatory program in adult pancreatic acinar cells triggered by Hippo signaling disruption
Jun Liu et al.
PLOS BIOLOGY (2019)
Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer
Nitin Raj et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
MK5 Regulates YAP Stability and Is a Molecular Target in YAP-Driven Cancers
Jimyung Seo et al.
CANCER RESEARCH (2019)
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas
Shigekazu Murakami et al.
DEVELOPMENTAL CELL (2019)
The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
Nesrin Hasan et al.
CANCERS (2019)
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
John M. Lamar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo
Imran Khan et al.
ONCOGENE (2019)
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation
Yoshihito Kano et al.
NATURE COMMUNICATIONS (2019)
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
Tamer A. Ahmed et al.
CELL REPORTS (2019)
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma
Bo Tu et al.
JCI INSIGHT (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
Dual Allosteric Inhibition of SHP2 Phosphatase
Michelle Fodor et al.
ACS CHEMICAL BIOLOGY (2018)
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Chiara Ambrogio et al.
CELL (2018)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity
Guanhua Rao et al.
EUROPEAN JOURNAL OF CANCER (2018)
The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell
Steven W. Plouffe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity
Takaaki Sugihara et al.
MOLECULAR CANCER RESEARCH (2018)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich A. Ruess et al.
NATURE MEDICINE (2018)
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
Sara Mainardi et al.
NATURE MEDICINE (2018)
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis
Alexander Greenhough et al.
EMBO MOLECULAR MEDICINE (2018)
Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling
Sebastian Mana-Capelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
Sebastian Mueller et al.
NATURE (2018)
Precancerous neoplastic cells can move through the pancreatic ductal system
Alvin P. Makohon-Moore et al.
NATURE (2018)
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1-and RAS-driven cancers
Robert J. Nichols et al.
NATURE CELL BIOLOGY (2018)
SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
Carmine Fedele et al.
CANCER DISCOVERY (2018)
The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ
Lei Chang et al.
NATURE (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival
Enrique Rozengurt et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
T. R. J. Evans et al.
ANNALS OF ONCOLOGY (2017)
Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization
Sungho Moon et al.
EMBO REPORTS (2017)
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
Paola Martinelli et al.
GUT (2017)
Inhibition of RAS function through targeting an allosteric regulatory site
Russell Spencer-Smith et al.
NATURE CHEMICAL BIOLOGY (2017)
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma
S. Murakami et al.
ONCOGENE (2017)
Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells
Fang Hao et al.
MOLECULAR CANCER RESEARCH (2017)
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Angela M. Krebs et al.
NATURE CELL BIOLOGY (2017)
Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis
Maria Teresa Salcedo Allende et al.
PANCREAS (2017)
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar et al.
NATURE COMMUNICATIONS (2017)
Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression
Rute M. M. Ferreira et al.
CELL REPORTS (2017)
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
Hung Yi Kristal Kaan et al.
SCIENTIFIC REPORTS (2017)
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
Yuan Si et al.
CANCER RESEARCH (2017)
RAS Proteins and Their Regulators in Human Disease
Dhirendra K. Simanshu et al.
CELL (2017)
ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis
Srinivas Vinod Saladi et al.
CANCER CELL (2017)
Upregulation of the expression of Wnt5a promotes the proliferation of pancreatic cancer cells in vitro and in a nude mouse model
Haiji Bo et al.
MOLECULAR MEDICINE REPORTS (2016)
p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells
J. M. Bailey et al.
ONCOGENE (2016)
YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling
Ralph Gruber et al.
GASTROENTEROLOGY (2016)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway
Peng Li et al.
GENES & DEVELOPMENT (2016)
Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD)
Jia Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen et al.
NATURE (2016)
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
Faiyaz Notta et al.
NATURE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
The role of wild type RAS isoforms in cancer
Bingying Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Control of YAP/TAZ Activity Metabolic anc Nutrient-Sensing Pathways
Giulia Santinon et al.
TRENDS IN CELL BIOLOGY (2016)
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Waltraut Lehmann et al.
NATURE COMMUNICATIONS (2016)
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer
Agnieszka K. Witkiewicz et al.
CELL REPORTS (2016)
The Roles of NDR Protein Kinases in Hippo Signalling
Alexander Hergovich
GENES (2016)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2015)
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Elena Enzo et al.
EMBO JOURNAL (2015)
TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells
Megan L. Finch-Edmondson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A gp130-Src-YAP module links inflammation to epithelial regeneration
Koji Taniguchi et al.
NATURE (2015)
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Jung-Soo Mo et al.
NATURE CELL BIOLOGY (2015)
AMPK modulates Hippo pathway activity to regulate energy homeostasis
Wenqi Wang et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Regulation of RAF protein kinases in ERK signalling
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2015)
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway
Xiaolin Nan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Xin Ye et al.
TRENDS IN CELL BIOLOGY (2015)
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Zhipeng Meng et al.
NATURE COMMUNICATIONS (2015)
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
Severa Bunda et al.
NATURE COMMUNICATIONS (2015)
Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
Dacheng Xie et al.
ONCOTARGET (2015)
Active YAP promotes pancreatic cancer cell motility, invasion and tumorigenesis in a mitotic phosphorylation-dependent manner through LPAR3
Shuping Yang et al.
ONCOTARGET (2015)
Disruption of p16 and Activation of Kras in Pancreas Increase Ductal Adenocarcinoma Formation and Metastasis in vivo
Wanglong Qiu et al.
Oncotarget (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Xaralabos Varelas
DEVELOPMENT (2014)
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
Jeffrey R. Infante et al.
EUROPEAN JOURNAL OF CANCER (2014)
Suppression of Feedback Loops Mediated by PI3K/mTOR Induces Multiple Overactivation of Compensatory Pathways: An Unintended Consequence Leading to Drug Resistance
Enrique Rozengurt et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Inhibition of Src Family Kinase Suppresses Pancreatic Cancer Cell Proliferation, Migration, and Invasion
Dong Wook Je et al.
PANCREAS (2014)
Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation
Severa Bunda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
KRAS: feeding pancreatic cancer proliferation
Kirsten L. Bryant et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
CDK1 Phosphorylation of YAP Promotes Mitotic Defects and Cell Motility and Is Essential for Neoplastic Transformation
Shuping Yang et al.
CANCER RESEARCH (2013)
The Hippo pathway: regulators and regulations
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
YAP1 oncogene and its eight isoforms
M. Sudol
ONCOGENE (2013)
EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
Carolina Navas et al.
CANCER CELL (2012)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Joseph Rosenbluh et al.
CELL (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP
Katrin Strassburger et al.
DEVELOPMENTAL BIOLOGY (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer
A. Hunter Shain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Oncogenic Ras/Src cooperativity in pancreatic neoplasia
D. J. Shields et al.
ONCOGENE (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
Erica L. Mayer et al.
CLINICAL CANCER RESEARCH (2010)
Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
Enrique Rozengurt et al.
CLINICAL CANCER RESEARCH (2010)
Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Jennifer P. Morton et al.
GASTROENTEROLOGY (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
A dimerization-dependent mechanism drives RAF catalytic activation
Thanashan Rajakulendran et al.
NATURE (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Precursors to invasive pancreatic cancer
A Maitra et al.
ADVANCES IN ANATOMIC PATHOLOGY (2005)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Src family kinases in tumor progression and metastasis
JM Summy et al.
CANCER AND METASTASIS REVIEWS (2003)
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins
F Kanai et al.
EMBO JOURNAL (2000)
Share Paper
